Urinary Metabolic Profiling of Liver Fluke-Induced Cholangiocarcinoma—A Follow-Up Study

Sithithaworn, 2012, The current status of Opisthorchiasis and Clonorchiasis in the Mekong basin, Parasitol Int, 61, 10, 10.1016/j.parint.2011.08.014 Khuntikeo, 2016, A comprehensive public health conceptual framework and strategy to effectively combat Cholangiocarcinoma in Thailand, PLoS Negl Trop Dis, 10, 10.1371/journal.pntd.0004293 Khuntikeo, 2014, Changing patterns of prevalence in Opisthorchis viverrini sensu lato infection in children and adolescents in Northeast Thailand, Acta Trop, 164, 469, 10.1016/j.actatropica.2016.10.017 Alsaleh, 2019, Characterisation of the urinary metabolic profile of liver fluke-associated cholangiocarcinoma, J Clin Exp Hepatol, 6, 657, 10.1016/j.jceh.2019.06.005 Alsaleh, 2019, Characterization of the urinary metabolic profile of cholangiocarcinoma in a United Kingdom population, Hepat Med, 11, 47, 10.2147/HMER.S193996 Alsaleh, 2021, Mapping of population disparities in the cholangiocarcinoma urinary metabolome, Sci Rep, 11, 10.1038/s41598-021-00530-0 Haznadar, 2019, Urinary metabolites diagnostic and prognostic of intrahepatic cholangiocarcinoma, Cancer Epidemiol Biomarkers Prev, 28, 1704, 10.1158/1055-9965.EPI-19-0453 Parker, 2014, Mass spectrometry based biomarker discovery, veriflcation, and validation - quality assurance and control of protein biomarker assays, Mol Oncol, 8, 840, 10.1016/j.molonc.2014.03.006 Xia, 2015, Metaboanalyst 3.0 — making metabolomics more meaningful, Nucleic Acid Res, 43, W251, 10.1093/nar/gkv380 Rotter, 2017, Stability of targeted metabolite profiles of urine samples under different storage conditions, Metabolomics, 13, 4, 10.1007/s11306-016-1137-z Annesley, 2003, Ion suppression in mass spectrometry, Clin Chem, 49, 1041, 10.1373/49.7.1041 Gregg, 1967, Presence of bile acids in jaundiced human urine, Nature, 214, 29, 10.1038/214029a0 Wang, 2010, Urinary metabolic proflling of colorectal carcinoma based on online afflnity solid phase extraction high performance liquid chromatography and ultra performance liquid chromatography mass spectrometry, Mol Biosyst, 6, 1947, 10.1039/c004994h Lehmann, 2010, Medium chain acylcarnitines dominate the metabolite pattern in humans under moderate intensity exercise and support lipid oxidation, PLoS One, 5, 10.1371/journal.pone.0011519 Younes, 1991, Metabolic alterations in obstructive jaundice: effect of duration of jaundice and bile-duct decompression, HPB Surg, 5, 35, 10.1155/1991/27457 Wang, 2016, Urine metabolic phenotypes analysis of extrahepatic cholangiocarcinoma disease using ultra high performance liquid chromatography mass spectrometry, RSC Adv, 6, 63049, 10.1039/C6RA09430A Shao, 2014, Development of urinary pseudotargeted lc-ms-based metabolomics method and its application in hepatocellular carcinoma biomarker discovery, J Proteome Res, 14, 906, 10.1021/pr500973d Chen, 2011, Serum and urine metabolite proflling reveals potential biomarkers of human hepatocellular carcinoma, Mol Cell Proteomics, 10 Wei, 2008, Nonalcoholic fatty liver disease and mitochondrial dysfunction, World J Gastroenterol, 14, 193, 10.3748/wjg.14.193 Abdenur, 2006, Aromatic l-aminoacid decarboxylase deflciency: unusual neonatal presentation and additional flndings in organic acid analysis, Mol Genet Metab, 87, 48, 10.1016/j.ymgme.2005.09.007 Zhang, 2009, Metabonomics study of atherosclerosis rats by ultra fast liquid chromatography coupled with ion trap-time of flight mass spectrometry, Talanta, 79, 836, 10.1016/j.talanta.2009.05.010 Gonzalez-Pena, 2016, Multiplatform metabolomic flngerprinting as a tool for understanding hypercholesterolemia in wistar rats, Eur J Nutr, 55, 997, 10.1007/s00394-015-0914-1 Huang, 2011, Bladder cancer determination via two urinary metabolites: a biomarker pattern approach, Mol Cell Proteomics, 10, 10.1074/mcp.M111.007922 Chen, 2009, Metabonomics study of liver cancer based on ultra performance liquid chromatography coupled to mass spectrometry with HILIC and RPLC separations, Anal Chim Acta, 650, 3, 10.1016/j.aca.2009.03.039 Lees, 2013, Hippurate: the natural history of a mammalian–microbial cometabolite, J Proteom Res, 12, 1527, 10.1021/pr300900b Dai, 2014, Study of urinary steroid hormone disorders: difference between hepatocellular carcinoma in early stage and cirrhosis, Anal Bioanal Chem, 406, 4325, 10.1007/s00216-014-7843-3 Alsaleh, 2018, Cholangiocarcinoma: a guide for the nonspecialist, Int J Gen Med, 12, 13, 10.2147/IJGM.S186854 Arlt, 2011, Urine steroid metabolomics as a biomarker tool for detecting malignancy in adrenal tumors, J Clin Endocrinol Metab, 96, 3775, 10.1210/jc.2011-1565 De Maria, 2002, Sex hormones and liver cancer, Mol Cell Endocrinol, 193, 59, 10.1016/S0303-7207(02)00096-5 Glaser, 2009, Cholangiocyte proliferation and liver flbrosis, Expert Rev Mol Med, 11, e7, 10.1017/S1462399409000994 Mancinelli, 2010, Role of sex hormones in the modulation of cholangiocyte function, World J Gastrointest Pathophysiol, 1, 50, 10.4291/wjgp.v1.i2.50 Alvaro, 1999, Biliary epithelium: a new chapter in cell biology, Ital J Gastroenterol Hepatol, 31, 78 Alvaro, 2006, Estrogens and the pathophysiology of the biliary tree, World J Gastroenterol, 12, 3537, 10.3748/wjg.v12.i22.3537 Mancino, 2009, Estrogens stimulate the proliferation of human cholangiocarcinoma by inducing the expression and secretion of vascular endothelial growth factor, Digest Liver Dis, 41, 156, 10.1016/j.dld.2008.02.015 Mancinelli, 2012, Recent advances in pathophysiology of biliary tree: influence of sex hormones in cholangiocyte growth, Prevent Res, 2, 221 Beyoglu, 2013, The metabolomic window into hepatobiliary disease, J Hepatol, 59, 842, 10.1016/j.jhep.2013.05.030 Reich, 2015, Tgr5 is essential for bile acid-dependent cholangiocyte proliferation in vivo and in vitro, Gut, 65, 487, 10.1136/gutjnl-2015-309458 Khuntikeo, 2015, Cohort proflle: cholangiocarcinoma screening and care program (CASCAP), BMC Cancer, 15, 459, 10.1186/s12885-015-1475-7 Marchesi, 2011, Towards the human colorectal cancer microbiome, PLoS One, 6, 10.1371/journal.pone.0020447 Seeree, 2015, An omics perspective on molecular biomarkers for diagnosis, prognosis, and therapeutics of cholangiocarcinoma, Int J Genomics, 2015, 10.1155/2015/179528 Duangkumpha, 2019, Urine proteomics study reveals potential biomarkers for the differential diagnosis of cholangiocarcinoma and periductal fibrosis, PLoS One, 14, 10.1371/journal.pone.0221024